Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21484374rdf:typepubmed:Citationlld:pubmed
pubmed-article:21484374lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C1710493lld:lifeskim
pubmed-article:21484374lifeskim:mentionsumls-concept:C1709630lld:lifeskim
pubmed-article:21484374pubmed:issue8lld:pubmed
pubmed-article:21484374pubmed:dateCreated2011-6-30lld:pubmed
pubmed-article:21484374pubmed:abstractTextWe determined whether [(18)F]fluorothymidine (FLT) positron emission tomography (PET) can detect early effects on tumor proliferation of JAC106, a new anti-tubulin agent.lld:pubmed
pubmed-article:21484374pubmed:languageenglld:pubmed
pubmed-article:21484374pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:citationSubsetIMlld:pubmed
pubmed-article:21484374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21484374pubmed:statusMEDLINElld:pubmed
pubmed-article:21484374pubmed:monthAuglld:pubmed
pubmed-article:21484374pubmed:issn1619-7089lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:LeeSeung...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:KimSung-BaeSBlld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:MoonDae...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:KimHwan...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:KangJong...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:OhSeung JunSJlld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:RyuJin-SookJSlld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:ParkSong-KyuS...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:KimMyung-HwaM...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:KangHye...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:KimSeog...lld:pubmed
pubmed-article:21484374pubmed:authorpubmed-author:ChungJin...lld:pubmed
pubmed-article:21484374pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21484374pubmed:volume38lld:pubmed
pubmed-article:21484374pubmed:ownerNLMlld:pubmed
pubmed-article:21484374pubmed:authorsCompleteYlld:pubmed
pubmed-article:21484374pubmed:pagination1436-48lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:meshHeadingpubmed-meshheading:21484374...lld:pubmed
pubmed-article:21484374pubmed:year2011lld:pubmed
pubmed-article:21484374pubmed:articleTitleEarly assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹?F]fluorothymidine in preclinical tumor models.lld:pubmed
pubmed-article:21484374pubmed:affiliationInstitute for Innovative Cancer Research, University of Ulsan College of Medicine, Asan Medical Center, Pungnap 2-dong, Songpa-gu, Seoul 138-736, Korea.lld:pubmed
pubmed-article:21484374pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21484374pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed